从心力衰竭和功能障碍到心脏综合征:TMAO可能是一个桥梁
Jialun Zhang1, Peining Zhu2, Siyu Li1
1Department of Cardiology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in pharmacology
|December 11, 2023
概括
三甲基胺N氧化物 (TMAO) 是肠道微生物的代谢物,与心脏和脏疾病有关. 研究正在探索TMAOO的研究.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學.
- 微生物组研究 微生物组研究
背景情况:
- 三甲基胺N氧化物 (TMAO) 是肠道微生物群的代谢物,与心力衰竭 (HF) 和慢性病 (CKD) 有关.
- 高的TMAO水平与慢性病患者的不良心血管事件和不良预后相关.
- 在心脏和脏疾病交叉的心脏和脏综合征 (CRS) 中TMAO的作用仍然在很大程度上未被探索.
研究的目的:
- 总结现有的关于TMAO在HF和病中的研究.
- 审查CRS目前的生物标志物.
- 探索TMAO作为CRS生物标志物的潜力及其对检测,预后和治疗的影响.
主要方法:
- 对TMAO在心血管和脏疾病中的作用的文献综述.
- 对现有的CRS生物标志物的分析.
- 探索运动,肠道微生物群和TMAO之间的关系.
主要成果:
- TMAO与心脏和脏疾病的病理生理学有关.
- 现有研究表明,TMAO影响慢性心力衰竭 (CHF) 和慢性病 (CKD) 的结果.
- 在TMAO和心综合征 (CRS) 之间的关联需要进一步的研究.
结论:
- TMAO可能作为心脏脏综合征 (CRS) 的潜在生物标志物.
- 需要进一步的研究来确定TMAO在CRS检测,预后和治疗评估中的作用.
- 了解TMAO与肠道微生物群和运动的联系,可能会提供新的治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:22Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:11Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95